---
title: "PTC Therapeutics (PTCT) Receives a Buy from Wells Fargo"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295781235.md"
description: "Wells Fargo analyst Benjamin Burnett maintained a Buy rating on PTC Therapeutics (PTCT) and set a price target of $109.00. This follows a recent Buy from Barclays's Eliana Merle, while RBC Capital had previously maintained a Hold rating on the stock."
datetime: "2026-08-13T10:16:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295781235.md)
  - [en](https://longbridge.com/en/news/295781235.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295781235.md)
generator: "portal-rs"
---

# PTC Therapeutics (PTCT) Receives a Buy from Wells Fargo

Wells Fargo analyst Benjamin Burnett maintained a Buy rating on PTC Therapeutics today and set a price target of $109.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Burnett covers the Healthcare sector, focusing on stocks such as Alkermes, MannKind, and Insmed. According to TipRanks, Burnett has an average return of 2.2% and a 45.63% success rate on recommended stocks. 

In addition to Wells Fargo, PTC Therapeutics also received a Buy from Barclays’s Eliana Merle in a report issued on August 3. However, on July 30, RBC Capital maintained a Hold rating on PTC Therapeutics (NASDAQ: PTCT).

### Related Stocks

- [PTCT.US](https://longbridge.com/en/quote/PTCT.US.md)
- [WFC.US](https://longbridge.com/en/quote/WFC.US.md)
- [ALKS.US](https://longbridge.com/en/quote/ALKS.US.md)
- [MNKD.US](https://longbridge.com/en/quote/MNKD.US.md)
- [INSM.US](https://longbridge.com/en/quote/INSM.US.md)
- [BARC.UK](https://longbridge.com/en/quote/BARC.UK.md)
- [BCS.US](https://longbridge.com/en/quote/BCS.US.md)
- [RY.US](https://longbridge.com/en/quote/RY.US.md)
- [WFC-D.US](https://longbridge.com/en/quote/WFC-D.US.md)
- [WFC-L.US](https://longbridge.com/en/quote/WFC-L.US.md)
- [WFC-Y.US](https://longbridge.com/en/quote/WFC-Y.US.md)
- [WFC-C.US](https://longbridge.com/en/quote/WFC-C.US.md)
- [WFC-Z.US](https://longbridge.com/en/quote/WFC-Z.US.md)
- [WFC-A.US](https://longbridge.com/en/quote/WFC-A.US.md)

## Related News & Research

- [PTC Therapeutics Targets Fabry Gene Therapy in $111M Bankruptcy Auction Deal](https://longbridge.com/en/news/296027001.md)
- [PTC Therapeutics Expands Rare Disease Portfolio with 'Unique Opportunity'](https://longbridge.com/en/news/295825875.md)
- [Why PTC Therapeutics (PTCT) Is Up 6.7% After Profit Beat, Higher Guidance And New Board Appointment](https://longbridge.com/en/news/295628654.md)
- [Mitsubishi UFJ Asset Management Co. Ltd. Buys 32,730 Shares of PTC Inc. $PTC](https://longbridge.com/en/news/296466346.md)
- [PTC Inc. $PTC Shares Sold by BlackRock Inc.](https://longbridge.com/en/news/296581223.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**